HomeNewsIndiaIndia working on aggressive strategy to attract FDI: Suresh Prabhu

India working on aggressive strategy to attract FDI: Suresh Prabhu

Prabhu in a virtual interaction with members of the Indo-Canadian Business Chamber (ICBC) recognized the impact of the COVID-19 pandemic and the changes it would bring to global business and trade practices, while outlining eight key areas of enhanced cooperation between India and Canada going forward, according to a statement.

May 05, 2020 / 20:53 IST
Story continues below Advertisement

India's Sherpa for G20 and G7 groups Suresh Prabhu on Tuesday said the government is working on an aggressive strategy to attract FDI into India in the aftermath of COVID-19 pandemic.

Prabhu in a virtual interaction with members of the Indo-Canadian Business Chamber (ICBC) recognized the impact of the COVID-19 pandemic and the changes it would bring to global business and trade practices, while outlining eight key areas of enhanced cooperation between India and Canada going forward, according to a statement.

Story continues below Advertisement

Coronavirus India News LIVE

He specifically listed out high-tech, financial services, capital investment, healthcare, manufacturing, environment, logistics and trade promotion as those that would see a major uptick between the two countries, the ICBC said in the statement.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show